Osteosarcoma and Its Variants

Overview

Journal Orthop Clin North Am

Specialty Orthopedics

Date 1996 Jul 1

PMID 8649738

Citations 21

Authors

R A Vander Griend

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma is the most common primary malignant tumor of bone. The variability of this tumor and its histologic variants in presentation, location, and biologic behavior has an influence on the prognosis and determines treatment options. Despite improvements in both survival and function due to limb salvage techniques and adjuvant chemotherapy, osteosarcoma continues to be a major challenge for the medical and surgical oncologist.

Citing Articles

The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.

Liu B, Liu X, Wang G, Chen Y Sci Rep. 2024; 14(1):5184.

PMID: 38431660 PMC: 10908810. DOI: 10.1038/s41598-024-55890-0.

Imatinib-Functionalized Galactose Hydrogels Loaded with Nanohydroxyapatite as a Drug Delivery System for Osteosarcoma: In Vitro Studies.

Sobierajska P, Wiatrak B, Jawien P, Janeczek M, Wiglusz K, Szelag A ACS Omega. 2023; 8(20):17891-17900.

PMID: 37251195 PMC: 10210190. DOI: 10.1021/acsomega.3c00986.

Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma.

Lin Y, Yang Y, Yuan K, Yang S, Zhang S, Li H Bioact Mater. 2022; 18:459-470.

PMID: 35415297 PMC: 8971536. DOI: 10.1016/j.bioactmat.2022.03.029.

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy.

Giatagana E, Berdiaki A, Gaardlos M, Samsonov S, N Tzanakakis G, Nikitovic D Cancers (Basel). 2022; 14(5).

PMID: 35267503 PMC: 8909324. DOI: 10.3390/cancers14051196.

Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.

Hu C, Liu C, Tian S, Wang Y, Shen R, Rao H BMC Cancer. 2020; 20(1):814.

PMID: 32854645 PMC: 7450807. DOI: 10.1186/s12885-020-07216-2.